miR-181d is a potential tumor suppressor in glioma that regulates important target genes involved in carcinogenesis, such as KRAS and BCL2 [57], and is involved in lymph node metastasis in oral squamous cell carcinoma [58]. Here, KRAS is linked to central nervous system cancer.